Dbr Bioresearch Ayurveda (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.30 M
as on 24-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Dbr Bioresearch Ayurveda (Opc)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Kumar serves as a director at the Company.
- CIN/LLPIN
U85100GJ2021OPC122791
- Company No.
122791
- Incorporation Date
22 May 2021
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dbr Bioresearch Ayurveda (Opc) Private Limited offer?
Dbr Bioresearch Ayurveda (Opc) Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs, Common Disease Medicines, Herbal Cough Syrup, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic & Herbal Health Supplement, Herbal Juice.
Who are the key members and board of directors at Dbr Bioresearch Ayurveda (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Kumar  | Director | 22-May-2021 | Current |
Financial Performance of Dbr Bioresearch Ayurveda (Opc).
Enhance accessibility to Dbr Bioresearch Ayurveda (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dbr Bioresearch Ayurveda (Opc)?
Unlock access to Dbr Bioresearch Ayurveda (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dbr Bioresearch Ayurveda (Opc)?
Dbr Bioresearch Ayurveda (Opc) has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dbr Bioresearch Ayurveda (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dbr Bioresearch Ayurveda (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
